blog patent-basics 
Patently O
NOVEMBER 20, 2022
Mike Brister is a theme park designer and I love his 2022 patent directed to a “vanishing illusion system.” The basic idea is that a portion of the glass is reflective while other portions are transparent. Patent examiner issued a first-action allowance on the following claim: 1. ” U.S. 11,235,258 .
FDA Law Blog
JULY 21, 2023
This series will provide an in-depth review of Hatch-Waxman and the BPCIA along with other IP basics relative to small molecules and biologics. This program will also lay the necessary foundation to understand the dynamics of the applicable patent life cycles for biopharmaceutical products and business development plans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JANUARY 2, 2023
Comprehend the structure of FDA and the roles of the three major agency centers: CDER, CBER and CDHR, master the basics of the application and approval processes for drugs and biologics, gain a practical working knowledge of clinical trial process for pharmaceutical products and much more! Karst (Director, Hyman, Phelps & McNamara P.C.).
Patently O
APRIL 3, 2024
192 (1883) in a blog post titled The Quest for a Meaningful Threshold of Invention. 320 (1945), an obviousness case decided just a few years before a rewriting of the 1952 Patent Act. Background on the Invention The challenged patent was U.S. Last week, I wrote about Atlantic Works v. Brady , 107 U.S. Dow Chemical Co.
Patently O
MAY 17, 2021
1] The topic is personal jurisdiction –when may a Federal Court exercise its power over an out-of-state patentee in a declaratory judgment action challenging the patent’s validity. Its sole employee is Robert Babayi–a patent attorney practicing in Washington DC who has apparently never visited the Texas office.
FDA Law Blog
AUGUST 4, 2022
The approval process, pre-approval concerns, product labeling, clinical trials, adverse events reports, patent concerns, and exclusivity – these are all critical aspects in the commercialization process for drugs and biologics that are governed by the FDA. MASTER the basics of the application and approval processes for drugs and biologics.
Patently O
JUNE 15, 2022
Starting with the skin structure, the relevant parts basically look like this: Figure 1: “Artist”‘s representation of skin layers. The opinion spends several pages discussing this; worthwhile reading if you are making a text-based argument, but too much depth to go into in a blog post. ” Slip Op. ” Id.
Expert insights. Personalized for you.
76 
Let's personalize your content